Prelude Therapeutics Incorporated (PRLD)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
3. 26
-0.06
-1.8072%
$
221.47M Market Cap
- P/E Ratio
- Div Yield
479,300 Volume
-2 Eps
$ 3.32
Previous Close Want to track PRLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Prelude Therapeutics Incorporated Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John H. Burbank III Passport Capital LLC | 10.12M | $305.1M | $33.91M | -$271.18M | -88.88% |
| CD Charlie Durham Sterling Capital Management LLC | 97 | $407.4 | $313.31 | -$94.09 | -23.1% |
 Joseph Castro Nuveen LLC | 37,023 | $155,496.6 | $119,584.29 | -$35,912.31 | -23.1% |
 Drew Phillips Fortitude Family Office LLC | 230 | $787 | $763.6 | -$23.4 | -2.97% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 18 | $75.6 | $59.76 | -$15.84 | -20.95% |
 Christopher C. Powers Farther Finance Advisors, LLC | 44 | $241.56 | $142.12 | -$99.44 | -41.17% |
 Mark Schafer Police & Firemen's Retirement System of New Jersey | 10,492 | $44,066.4 | $33,889.16 | -$10,177.24 | -23.1% |
2026 © Marketlog. All Rights Reserved.
